Although, recent studies have revealed that the inhibition of ATGL via RNAi or a small molecule inhibitor attenuated the growth and motility of tumor cells (colorectal cancer cells and non-small cell lung carcinomas cells) [8], However, whether it contributes to tumor growth, or other functions in HCC remains unclear. Here, PNPLA2 is linked to hepatocellular carcinoma.